Last reviewed · How we verify

NCT06324708: THA_DXA

Analysis of Defined Elements on DXA in Patients Undergoing Hip Arthroplasty

Status unknown NA Last updated 22 March 2024
What this trial tests

NA trial testing DXA in Bone Resorption in 69 participants. Status unknown.

Timeline
7 February 2023
Primary endpoint
31 October 2024
31 October 2025

Quick facts

Lead sponsorI.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment69
Start date7 February 2023
Primary completion31 October 2024
Estimated completion31 October 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio — full company profile →

Who can join

Adults 50 to 90, any sex, with Bone Resorption or Arthroplasty Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the role of two-dimensional FEM models obtained from DXA images in the longitudinal assessment of periprosthetic bone, in subjects undergoing hip arthroplasty. Specifically, the study will focus on the joint analysis of changes in the parameters of bone mineral density (BMD) and Bone Strain Index (BSI) at the level of periprosthetic bone of the proximal femur in patients undergoing hip replacement surgery using DXA, evaluating the densitometric variation of these two parameters over time, starting from an immediately postoperative data and checking the change at 6 months to follow the patient through the postoperative course

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of DXA

Trials testing the same drug.

Other recruiting trials for Bone Resorption

Currently open trials in the same condition.

Other I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06324708.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing